BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27979325)

  • 1. Early cognitive impairment along with decreased stress-induced BDNF in male and female patients with newly diagnosed multiple sclerosis.
    Prokopova B; Hlavacova N; Vlcek M; Penesova A; Grunnerova L; Garafova A; Turcani P; Kollar B; Jezova D
    J Neuroimmunol; 2017 Jan; 302():34-40. PubMed ID: 27979325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
    Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
    Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burnout and cognitive impairment: Associated with serum BDNF in a Chinese Han population.
    He SC; Zhang YY; Zhan JY; Wang C; Du XD; Yin GZ; Cao B; Ning YP; Soares JC; Zhang XY
    Psychoneuroendocrinology; 2017 Mar; 77():236-243. PubMed ID: 28119229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
    Mehrpour M; Akhoundi FH; Delgosha M; Keyvani H; Motamed MR; Sheibani B; Meysamie A
    Neurologist; 2015 Oct; 20(4):57-60. PubMed ID: 26468869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
    Vogel SWN; Bijlenga D; Verduijn J; Bron TI; Beekman ATF; Kooij JJS; Penninx BWJH
    Psychoneuroendocrinology; 2017 May; 79():31-39. PubMed ID: 28249186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
    Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
    Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?
    Mitoma M; Yoshimura R; Sugita A; Umene W; Hori H; Nakano H; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):679-85. PubMed ID: 18160197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
    Kochanowski J; Uchman D; Litwiniuk A; Kalisz M; Wolinska-Witort E; Martynska L; Baranowska B; Bik W
    Neuro Endocrinol Lett; 2015; 36(2):148-52. PubMed ID: 26071584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.
    Wang Y; Liu H; Zhang BS; Soares JC; Zhang XY
    Parkinsonism Relat Disord; 2016 Aug; 29():66-71. PubMed ID: 27245919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress.
    Naert G; Ixart G; Maurice T; Tapia-Arancibia L; Givalois L
    Mol Cell Neurosci; 2011 Jan; 46(1):55-66. PubMed ID: 20708081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
    Nascimento CM; Pereira JR; Pires de Andrade L; Garuffi M; Ayan C; Kerr DS; Talib LL; Cominetti MR; Stella F
    J Alzheimers Dis; 2015; 43(1):81-91. PubMed ID: 25062900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cognitive training on the expression of brain-derived neurotrophic factor in lymphocytes of mild cognitive impairment patients.
    Casoli T; Giuli C; Balietti M; Giorgetti B; Solazzi M; Fattoretti P
    Rejuvenation Res; 2014 Apr; 17(2):235-8. PubMed ID: 24127698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress.
    Tamaji A; Iwamoto K; Kawamura Y; Takahashi M; Ebe K; Kawano N; Kunimoto S; Aleksic B; Noda Y; Ozaki N
    Hum Psychopharmacol; 2012 May; 27(3):329-33. PubMed ID: 22344744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF and Tau as biomarkers of severity in multiple sclerosis.
    Islas-Hernandez A; Aguilar-Talamantes HS; Bertado-Cortes B; Mejia-delCastillo GJ; Carrera-Pineda R; Cuevas-Garcia CF; Garcia-delaTorre P
    Biomark Med; 2018 Jul; 12(7):717-726. PubMed ID: 29865854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Biomarkers and Cognitive Function in a Long-Term Prospective Population-based Study of Aging US Adults.
    Paulsen AJ; Schubert CR; Pinto A; Carlsson CM; Chappell RJ; Fischer ME; Klein BEK; Klein R; Tsai MY; Cruickshanks KJ
    Alzheimer Dis Assoc Disord; 2020; 34(1):31-39. PubMed ID: 31385821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.